Listen

Description

How do you turn neuroscience ideas into real businesses without losing sight of the science? In this episode of The Business of Neurotech, host Adam Fraser sits down with neuroscientist, author, podcaster, entrepreneur, and Stanford educator David Eagleman to explore his journey across academia and neurotech startups. David discusses how he shifted from running a traditional neuroscience lab to building ventures in sensory substitution, digital cognitive assessment, and companion robotics, and delves into what he has learned about markets, investors, regulation, and founder decision-making along the way. Adam and David also discuss why some neurotech ideas struggle to find the right market, the balance between wellness and regulated health technology, and why the next wave of BCI may go beyond metal electrodes. Tune in to hear David’s take on building in neurotech, where the field is heading, and what it really takes to turn big ideas into lasting companies.

Key Points From This Episode:

Links Mentioned in Today’s Episode:

David Eagleman

David Eagleman on X

David Eagleman on Facebook

David Eagleman on Instagram

David Eagleman on LinkedIn

David Eagleman on TikTok

David Eagleman on Bluesky

Inner Cosmos Podcast

Stanford University

BrainCheck

Jojo Health 

Science Corporation

Subsense

Adam Fraser on LinkedIn

Omniscient Neurotechnology

The Business of Neurotech Podcast